TARO FDA Approval ANDA 086156

ANDA 086156

TARO

FDA Drug Application

Application #086156

Application Sponsors

ANDA 086156TARO

Marketing Status

Discontinued001

Application Products

001OINTMENT;TOPICAL0.2%0NITROFURAZONENITROFURAZONE

FDA Submissions

ORIG1AP1978-08-15
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1982-06-29
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1982-08-25
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1984-08-28
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1985-11-18
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1985-12-06
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1986-08-08
LABELING; LabelingSUPPL16AP1989-02-16
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1989-05-11
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1989-05-11
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1989-08-18
LABELING; LabelingSUPPL20AP1992-07-28
LABELING; LabelingSUPPL21AP1992-09-14

Submissions Property Types

SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL10Null0
SUPPL11Null0
SUPPL13Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0

CDER Filings

TARO
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 86156
            [companyName] => TARO
            [docInserts] => ["",""]
            [products] => [{"drugName":"NITROFURAZONE","activeIngredients":"NITROFURAZONE","strength":"0.2%","dosageForm":"OINTMENT;TOPICAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NITROFURAZONE","submission":"NITROFURAZONE","actionType":"0.2%","submissionClassification":"OINTMENT;TOPICAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.